Simulated presence therapy for dementia

Cochrane Database of Systematic Reviews

Volumn 2017, Issue 4, 2017, Pages

  Abraha, Iosief ^a   Rimland, Joseph M ^a   Lozano Montoya, Isabel ^b   Dell'Aquila, Giuseppina ^a   Vélez Díaz Pallarés, Manuel ^b   Trotta, Fabiana M ^a   Cruz Jentoft, Alfonso J ^b   Cherubini, Antonio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL OUTCOME; DEMENTIA; HUMAN; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIMULATED PRESENCE THERAPY; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; THERAPY EFFECT; DEPRESSION; FAMILY; FEMALE; MALE; PSYCHOLOGY; PSYCHOMOTOR AGITATION; RECORDING; VERY ELDERLY; VIDEORECORDING;

AGED, 80 AND OVER; DEMENTIA; DEPRESSION; FAMILY; FEMALE; HUMANS; MALE; PSYCHOMOTOR AGITATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TAPE RECORDING; VIDEOTAPE RECORDING;

EID: 85018488848     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011882.pub2     Document Type: Review

References (68)

1. Camberg L, Woods P, Ooi WL, Hurley A, Volicer L, Ashley J, et al. Evaluation of Simulated Presence: a personalized approach to enhance well-being in persons with Alzheimer's disease. Journal of the American Geriatrics Society 1999;47(4):446-52. [PUBMED: 10203120]5417765
2. Cohen-Mansfield J, Werner P. Management of verbally disruptive behaviors in nursing home residents. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 1997;52(6):M369-77. [PUBMED: 9402944]5417767
3. Garland K, Beer E, Eppingstall B, O'Connor DW. A comparison of two treatments of agitated behavior in nursing home residents with dementia: simulated family presence and preferred music. American Journal of Geriatric Psychiatry 2007;15(6):514-21. [PUBMED: 17293386]5417769
4. Cheston R, Thorne K, Whitby P, Peak J. Simulated presence therapy, attachment and separation amongst people with dementia. Dementia 2007;6(3):442-9. 5417771
5. Evans N, Cheston R, Harris N. Personal message cards: An evaluation of an alternative method of delivering simulated presence therapy. Dementia-international journal of social research and practice 2016;6:1703-15. 5417773
6. Kajiyama BK, Dib LRC, Tymchuk AJ, Boxer AL, Kixmiller JS, Olinsky CJ. Improving the quality of life for caregivers and care recipients with personalized video channels. Clinical Gerontologist 2007;31(1):95-100. 5417775
7. Miller S, Vermeersch PE, Bohan K, Renbarger K, Kruep A, Sacre S. Audio presence intervention for decreasing agitation in people with dementia. Geriatric Nursing (New York, N.Y.) 2001;22(2):66-70. [PUBMED: 11326212]5417777
8. O'Connor CM, Smith R, Nott MT, Lorang C, Mathews RM. Using video simulated presence to reduce resistance to care and increase participation of adults with dementia. American Journal of Alzheimer's Disease and Other Dementias 2011;26(4):317-25. [PUBMED: 21624886]5417779
9. Peak JS, Cheston RI. Using simulated presence therapy with people with dementia. Aging & Mental Health 2002;6(1):77-81. 5417781
10. Smith R, Campbell A, Lorang C, Mathews M, O'Connor C. Video technology and simulated presence to assist in dementia care. Australasian Journal on Ageing. 2010; Vol. 29:40. 5417783
11. Woods P, Ashley J. Simulated presence therapy: using selected memories to manage problem behaviors in Alzheimer's disease patients. Geriatric Nursing 1995;16(1):9-14. 5417785
12. Zetteler J. Effectiveness of simulated presence therapy for individuals with dementia: a systematic review and meta-analysis. Aging & Mental Health 2008;12(6):779-85. [PUBMED: 19023729]5417787
13. Abraha I, Cherubini A, Cozzolino F, De Florio R, Luchetta ML, Rimland JM, et al. Deviation from intention to treat analysis in randomised trials and treatment effect estimates: meta-epidemiological study. BMJ 2015;350:h2445. [PUBMED: 26016488]
14. Abraha I, Cruz-Jentoft A, Soiza RL, O'Mahony D, Cherubini A. Evidence of and recommendations for non-pharmacological interventions for common geriatric conditions: the SENATOR-ONTOP systematic review protocol. BMJ open 2015;5(1):e007488. [PUBMED: 25628049]
15. Abraha I, Rimland JM, Trotta FM, Dell'Aquila G, Cruz-Jentoft A, Petrovic M, et al. Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series. BMJ open 2017;7(3):e012759. [PUBMED: 28302633]
16. Algase DL, Beck C, Kolanowski A, Whall A, Berent S, Richards K, et al. Need-driven dementia-compromised behavior: An alternative view of disruptive behavior. American Journal of Alzheimer's Disease and Other Dementias 1996;11(6):10-9.
17. Balshem H, Helfand M, Schunemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401-6. [PUBMED: 21208779]
18. Borson S, Raskind MA. Clinical features and pharmacologic treatment of behavioral symptoms of Alzheimer's disease. Neurology 1997;48(5 Suppl 6):S17-24. [PUBMED: 9153156]
19. Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. New England Journal of Medicine 2011;365(21):2002-12.
20. Cameron M, Lonergan E, Lee H. Transcutaneous electrical nerve stimulation (TENS) for dementia. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD004032]
21. Cerejeira J, Lagarto L, Mukaetova-Ladinska EB. Behavioral and psychological symptoms of dementia. Frontiers in Neurology 2012;3:73.
22. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004;291(20):2457-65. [PUBMED: 15161896]
23. Cherubini A, Ruggiero C, Dell'Aquila G, Eusebi P, Gasperini B, Zengarini E, et al. Underrecognition and undertreatment of dementia in Italian nursing homes. Journal of the American Medical Directors Association 2012;13(8):759.e7-13. [PUBMED: 22727993]
24. Chung JC, Lai CK, Chung PM, French HP. Snoezelen for dementia. Cochrane Database of Systematic Reviews 2002, Issue 4. [DOI: 10.1002/14651858.CD003152]
25. Clyburn LD, Stones MJ, Hadjistavropoulos T, Tuokko H. Predicting caregiver burden and depression in Alzheimer's disease. Journals of Gerontology. Series B, Psychological Sciences and Social Sciences 2000;55(1):S2-13. [PUBMED: 10728125]
26. Deeks JJK, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
27. Thompson Reuters. EndNote reference management software. Thompson Reuters, 2013.
28. Forbes D, Thiessen EJ, Blake CM, Forbes SC, Forbes S. Exercise programs for people with dementia. Cochrane Database of Systematic Reviews 2013, Issue 12. [DOI: 10.1002/14651858.CD006489]
29. Forbes D, Blake CM, Thiessen EJ, Peacock S, Hawranik P. Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia. Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD003946]
30. Forrester LT, Maayan N, Orrell M, Spector AE, Buchan LD, Soares-Weiser K. Aromatherapy for dementia. Cochrane Database of Systematic Reviews 2014, Issue 2. [DOI: 10.1002/14651858.CD003150.pub2]
31. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
32. Howard R, McShane R, Lindesay J, Ritchie C, Baldwin A, Barber R, et al. Donepezil and memantine for moderate-to-severe Alzheimer's disease. New England Journal of Medicine 2012;366(10):893-903.
33. Kales HC, Gitlin LN, Lyketsos CG. Assessment and management of behavioral and psychological symptoms of dementia. BMJ (Clinical Research Ed.) 2015;350:h369. [PUBMED: 25731881]
34. Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. International Journal of Geriatric Psychiatry 2007;22(5):475-84.
35. Kunik ME, Snow AL, Davila JA, Steele AB, Balasubramanyam V, Doody RS, et al. Causes of aggressive behavior in patients with dementia. Journal of Clinical Psychiatry 2010;71(9):1145-52. [PUBMED: 20361896]
36. Leendertse AJ, Van Den Bemt PM, Poolman JB, Stoker LJ, Egberts AC, Postma MJ. Preventable hospital admissions related to medication (HARM): cost analysis of the HARM study. Value in Health 2011;14(1):34-40.
37. Lopez OL, Becker JT, Chang YF, Sweet RA, Aizenstein H, Snitz B, et al. The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer's disease. American Journal of Psychiatry 2013;170(9):1051-8.
38. Lyketsos CG. Neuropsychiatric symptoms (behavioral and psychological symptoms of dementia) and the development of dementia treatments. International Psychogeriatrics / IPA 2007;19(3):409-20. [PUBMED: 17346363]
39. Macura A, Abraha I, Kirkham J, Gensini GF, Moja L, Iorio A. Selective outcome reporting: telling and detecting true lies. The state of the science. Internal and Emergency Medicine 2010;5(2):151-5. [PUBMED: 20300879]
40. Miesen BML. Alzheimer's disease, the phenomenon of parent fixation and Bowlby's attachment theory. International Journal of Geriatric Psychiatry 1993;8(2):147-53.
41. Moniz-Cook ED, Swift K, James I, Malouf R, De Vugt M, Verhey F. Functional analysis-based interventions for challenging behaviour in dementia. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD006929.pub2; PUBMED: 22336826]
42. Neal M, Barton Wright P. Validation therapy for dementia. Cochrane Database of Systematic Reviews 2003, Issue 3. [DOI: 10.1002/14651858.CD001394]
43. O'Connor DW, Ames D, Gardner B, King M. Psychosocial treatments of psychological symptoms in dementia: a systematic review of reports meeting quality standards. International Psychogeriatrics 2009;21(2):241-51. [PUBMED: 19138459]
44. Olin J, Schneider L. Galantamine for Alzheimer's disease. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD001747]
45. Opie J, Rosewarne R, O'Connor DW. The efficacy of psychosocial approaches to behaviour disorders in dementia: a systematic literature review. Australian and New Zealand Journal of Psychiatry 1999;33(6):789-9.
46. Peng WN, Zhao H, Liu ZS, Wang S. Acupuncture for vascular dementia. Cochrane Database of Systematic Reviews 2007, Issue 2. [DOI: 10.1002/14651858.CD004987.pub2]
47. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP. The global prevalence of dementia: a systematic review and meta-analysis. Alzheimer's & Dementia 2013;9(1):63-75 e2.
48. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
49. Rottenkolber D, Schmiedl S, Rottenkolber M, Farker K, Salje K, Mueller S, et al. Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. Pharmacoepidemiology and Drug Safety 2011;20(6):626-34.
50. Salzman C, Jeste DV, Meyer RE, Cohen-Mansfield J, Cummings J, Grossberg GT, et al. Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. Journal of Clinical Psychiatry 2008;69(6):889-98. [PUBMED: 18494535]
51. Savovic J, Jones H, Altman D, Harris R, Juni P, Pildal J, et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. Health Technology Assessment (Winchester, England) 2012;16(35):1-82. [PUBMED: 22989478]
52. Savva GM, Zaccai J, Matthews FE, Davidson JE, McKeith I, Brayne C. Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population. British Journal of Psychiatry 2009;194(3):212-9.
53. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
54. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
55. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005;293(5):596-608.
56. Smith M, Gerdner LA, Hall GR, Buckwalter KC. History, development, and future of the progressively lowered stress threshold: a conceptual model for dementia care. Journal of the American Geriatrics Society 2004;52(10):1755-60. [PUBMED: 15450057]
57. Spalletta G, Musicco M, Padovani A, Rozzini L, Perri R, Fadda L, et al. Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease. American Journal of Geriatric Psychiatry 2010;18(11):1026-35. [PUBMED: 20808086]
58. Steinberg M, Shao H, Zandi P, Lyketsos CG, Welsh-Bohmer KA, Norton MC, et al. Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. International Journal of Geriatric Psychiatry 2008;23(2):170-7. [PUBMED: 17607801]
59. Stern Y, Albert M, Brandt J, Jacobs DM, Tang MX, Marder K, et al. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study. Neurology 1994;44(12):2300-7.
60. Thies W, Bleiler . 2012 Alzheimer's disease facts and figures. Alzheimer's & Dementia 2012;8(2):131-68. [PUBMED: 22404854]
61. Van Den Wijngaart MA, Vernooij-Dassen MJ, Felling AJ. The influence of stressors, appraisal and personal conditions on the burden of spousal caregivers of persons with dementia. Aging & Mental Health 2007;11(6):626-36. [PUBMED: 18074250]
62. Viggo Hansen N, Jørgensen T, Ørtenblad L. Massage and touch for dementia. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD004989.pub2]
63. Vink AC, Birks JS, Bruinsma MS, Scholten RJ. Music therapy for people with dementia. Cochrane Database of Systematic Reviews 2004, Issue 3. [DOI: 10.1002/14651858.CD003477.pub2]
64. Wimo A, Jonsson L, Bond J, Prince M, Winblad B. The worldwide economic impact of dementia 2010. Alzheimer's & Dementia 2013;9(1):1-11. [PUBMED: 23305821]
65. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clinical Research Ed.) 2008;336(7644):601-5. [PUBMED: 18316340]
66. Woods RT, Bruce E, Edwards RT, Hounsome B, Keady J, Moniz-Cook ED, et al. Reminiscence groups for people with dementia and their family carers: pragmatic eight-centre randomised trial of joint reminiscence and maintenance versus usual treatment: a protocol. Trials 2009;10:64. [PUBMED: 19642992]
67. Abraha I, Rimland Joseph M, Lozano-Montoya I, Dell'Aquila G, Vélez-Díaz-Pallarés M, Trotta Fabiana M, et al. Simulated presence therapy for dementia. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2015, issue 9. [DOI: 10.1002/14651858.CD011882; CD011882]
68. Abraha I, Rimland JM, Lozano-Montoya I, Dell'Aquila G, Velez-Diaz-Pallares M, Trotta FM, et al. Simulated presence therapy for dementia: a systematic review protocol. BMJ open 2016;6(5):e011007. [PUBMED: 27169742]